Cardiac Surveillance for Anti-HER2 Chemotherapy P Collier, M Hussain, Z B Popovic, et. al. Cleve…
Cardiotossicità da anti-HER2
-
-
Management of trastuzumab cardiotoxicity (breast and gastric cancer) (Thanks to oncologist Alessandro Inno for sharing this presentation...
-
JACC: CardioOncology June 01, 2020 | Vol. 2 No. 2 – Table of Contents of…
-
Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2- positive breast cancer Noam Pondé, Lieveke Ameye, Matteo…
-
Effects of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on cancer therapy-related cardiac dysfunction: a meta-analysis…
-
A case of left ventricular assist device application for chemotherapy-related cardiomyopathy caused by trastuzumab and…
-
Cardiotoxicity due to anti-HER2 agents
-
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy Calvillo-Argüelles O, Abdel-Qadir…
-
Association between obesity and trastuzumab-related cardiac toxicity in elderly patients with breast cancer Hai-Yan Wang,…
-
JACC: CardioOncology September 01, 2019 | Vol. 1 No. 1 – Table of Contents of…